Bioline Rx reported $-2.59M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Arca Biopharma USD -29.58M 694K Dec/2025
Bio Path USD -976K 3.62M Sep/2025
Bioline Rx USD -2.59M 352K Mar/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025